Debra Richardson to Multicenter Studies as Topic
This is a "connection" page, showing publications Debra Richardson has written about Multicenter Studies as Topic.
Connection Strength
0.060
-
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. Int J Gynecol Cancer. 2024 Aug; 34(8):1283-1289.
Score: 0.060